Metabolic & Body Comp
Preclinical
Research chemical

5-Amino-1MQ

Also known as 5-Amino-1-methylquinolinium · NNMT inhibitor

New

Reconstitution & dosing guide

10 mg vial — research phases, recon steps, and a live unit calculator.

Open guide

Available sizes & price

Catalog only

10mg x 10 vials

5-amino 10 · Not in current stock

$20 / vial

Add

50mg x 60

5-Amino-1MQ Capsules · Not in current stock

$35 / vial

Add

Prices per vial · Research use only · Not medical advice.

Small-molecule NNMT inhibitor often grouped with peptides in biohacking shops; metabolic research compound.

How to picture it

NNMT can act like a side drain in cellular metabolic accounting — consuming methyl resources and blunting efficiency. 5-Amino-1MQ is studied as a way to plug that drain so energy and fat-metabolism pathways keep more of what they need. Picture metabolic efficiency at the enzyme level: not a stimulant force, but closing a leak in the accounting so fuel-handling programs run cleaner.

Research focus & benefits

  • NNMT inhibition and metabolic efficiency research
  • Fat-metabolism and energy-pathway interest
  • Methyl-resource conservation studies

Benefits describe research interest and pathway rationale — not guaranteed outcomes or medical advice. Research use only.

Overview

Though not a peptide, 5-Amino-1MQ is widely sold alongside peptide catalogs. It inhibits nicotinamide N-methyltransferase (NNMT), an enzyme linked to metabolic inefficiency in fat tissue research. Oral capsules are common in research markets.

Mechanism

NNMT inhibition may increase NAD+ salvage efficiency and influence adipocyte metabolism in preclinical models.

Research uses

  • Obesity and adipose biology
  • NAD+ metabolism research

Research dosing notes

Research chemical dosing is speculative; not an approved weight-loss drug.

Open full reconstitution & dosing guide →

Half-life / kinetics

Not as well characterized publicly as major drugs

Common research routes

Oral

Reported considerations

  • Limited human data
  • GI upset possible
  • Unknown long-term profile

Contraindications / cautions

  • Pregnancy
  • Serious disease self-treatment

Common research stacks

  • GLP-1s (speculative)
  • Exercise
  • MOTS-c discussions

Legal / access note

Research compound commonly adjacent to peptide markets; not a peptide and not FDA-approved for fat loss.